Study Finds Cell-Death Vulnerability in IBD Tissue During Clinical Remission

Comparing cell death in biopsies and organoids

According to ScienceAlert, researchers examined intestinal biopsies from 80 people with and without IBD, most of whom had inactive or mildly active disease. They reported signals associated with necroptosis in patient tissue, including tissue without obvious inflammation.

In laboratory-grown miniature intestinal tissues called organoids, inflammatory signals instead led mainly to apoptosis. Blocking necroptosis did not stop cell death under the tested conditions.

Clinical remission indicates that IBD activity has subsided, but it does not by itself establish whether the intestinal lining's underlying biology has returned to normal.

The reported study identified cell-death-related signals in patient tissue during clinically controlled IBD and found a different predominant cell-death response in inflammation-exposed organoids. Its small follow-up analysis did not show that the marker can predict an individual flare.

Clinical remission may differ from gut-lining recovery

The findings offer a possible explanation for why IBD can flare after symptoms improve: clinical remission may not reflect full recovery of the gut lining. However, no safe treatment has been shown to prevent flares by blocking these mechanisms, and the reported follow-up was preliminary.